Evidence map›Paper›PMID 32601469›Full record

ArticleNature immunology2020

Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis.

Yong Hwan Park, Elaine F Remmers, Wonyong Lee, Amanda K Ombrello, Lawton K Chung, Zhao Shilei, Deborah L Stone, Maya I Ivanov, Nicole A Loeven, Karyl S Barron and 14 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 148 citations in OpenAlex.

  1. Review
  2. Review
  3. ThebioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Frontiers in pharmacology · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 4 countries.

Yong Hwan Park *Inflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
Elaine F Remmers *Inflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-9522-1249
Wonyong LeeInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-4412-8519
Amanda K OmbrelloInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
Lawton K ChungDepartment of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Zhao ShileiBeijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China.
Deborah L StoneInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
Maya I IvanovDepartment of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Nicole A LoevenDepartment of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Karyl S BarronDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Patrycja HoffmannInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
Michele NehrebeckyInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
Yeliz Z Akkaya-UlumDepartment of Medical Biology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Erdal SagDepartment of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Banu Balci-PeynirciogluDepartment of Medical Biology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ivona AksentijevichInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
Ahmet GülDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Charles N RotimiCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD, USA.
Hua ChenBeijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0002-9829-6561
James B BliskaDepartment of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Seza OzenDepartment of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Daniel L KastnerInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA. dan.kastner@nih.gov.ORCID http://orcid.org/0000-0001-7188-4550
Daniel ShrinerCenter for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD, USA.
Jae Jin ChaeInflammatory Disease Section, Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, Bethesda, MD, USA. chaej@mail.nih.gov.ORCID http://orcid.org/0000-0003-0719-4349
National Human Genome Research Institute · USHacettepe University · TRChinese Academy of Sciences · CNDartmouth College · USStony Brook University · USIstanbul University · TRNational Institute of Allergy and Infectious Diseases · US

Funding

Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory DiseasesZIAHG200372 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI KASTNER, DANIEL · 2011 to 2025
$27.2M
Genetics, Natural History, and Pathophysiology of Behcet's DiseaseZIAHG200374 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI KASTNER, DANIEL · 2011 to 2020
$10.5M
Regulation of host innate and adaptive immunity by bacterial type III effectorsR01AI099222 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLISKA, JAMES B · 2012 to 2025
$5.9M
Dartmouth Cystic Fibrosis Training ProgramT32HL134598 · NHLBI · DARTMOUTH COLLEGE · PI George A. O'Toole · 2017 to 2026
$1.7M
Intramural NIH HHS ZIA HG200372Intramural NIH HHS ZIA HG200374NHLBI NIH HHS T32 HL134598NIAID NIH HHS R01 AI099222
6 · The paper itself

Abstract

Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by homozygous or compound heterozygous gain-of-function mutations in MEFV, which encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for multiple MEFV mutations are high in several Mediterranean populations, suggesting that they confer selective advantage. Among 2,313 Turkish people, we found extended haplotype homozygosity flanking FMF-associated mutations, indicating evolutionarily recent positive selection of FMF-associated mutations. Two pathogenic pyrin variants independently arose >1,800 years ago. Mutant pyrin interacts less avidly with Yersinia pestis virulence factor YopM than with wild-type human pyrin, thereby attenuating YopM-induced interleukin (IL)-1β suppression. Relative to healthy controls, leukocytes from patients with FMF harboring homozygous or compound heterozygous mutations and from asymptomatic heterozygous carriers released heightened IL-1β specifically in response to Y. pestis. Y. pestis-infected Mefv

Indexed as

PlagueAnimalsBacterial Outer Membrane ProteinsDisease ResistanceFamilial Mediterranean FeverHaplotypesHumansInflammasomesMiceMice, Inbred C57BLMutationPyrinSelection, GeneticTurkeyVirulence FactorsYersinia pestisBacterial Outer Membrane ProteinsInflammasomesMEFV protein, humanPyrinVirulence FactorsyopM protein, Yersinia

Identifiers

PMID32601469
PMCPMC7381377
OpenAlexW3038065835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.